
Medicamen Biotech MEBI.NS rises as much as 5.3% to 523 rupees
Co signs 10-year contract manufacturing deal with a US-based pharma distributor and marketing firm; financials not disclosed but 25% payment due upfront
Over 12,000 shares traded as of 9:46 a.m. IST, over half of their 30-day moving avg
Stock last up 4.7%, cutting YTD losses to 3.1%